 | • レポートコード：D0GIR-02226 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、非血液がん治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。非血液がん治療の種類別市場規模（化学療法、外科、放射線療法、その他）、用途別市場規模（病院、腫瘍治療センター、外来手術センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis、Johnson & Johnson、Pfizer、Astellas Pharma、Bristol-Myers Squibb、Amgen、Roche ・地域別グローバル市場分析 2015年-2020年 ・非血液がん治療の北米市場（アメリカ、カナダ、メキシコ） ・非血液がん治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・非血液がん治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・非血液がん治療の南米市場（ブラジル、アルゼンチン） ・非血液がん治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：化学療法、外科、放射線療法、その他 ・用途別分析：病院、腫瘍治療センター、外来手術センター、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Non-Hematological Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Non-Hematological Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Non-Hematological Cancer Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Non-Hematological Cancer Treatment market has been segmented into:
Chemotherapy
Surgery
Radiation Therapy
Others
By Application, Non-Hematological Cancer Treatment has been segmented into:
Hospitals
Oncology Treatment Centre
Ambulatory Surgery Centers
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Non-Hematological Cancer Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Non-Hematological Cancer Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Non-Hematological Cancer Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Non-Hematological Cancer Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Non-Hematological Cancer Treatment Market Share Analysis
Non-Hematological Cancer Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Non-Hematological Cancer Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Non-Hematological Cancer Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Non-Hematological Cancer Treatment are:
Novartis
Johnson & Johnson
Pfizer
Astellas Pharma
Bristol-Myers Squibb
Amgen
Roche
Table of Contents
1 Non-Hematological Cancer Treatment Market Overview
1.1 Product Overview and Scope of Non-Hematological Cancer Treatment
1.2 Classification of Non-Hematological Cancer Treatment by Type
1.2.1 Global Non-Hematological Cancer Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Non-Hematological Cancer Treatment Revenue Market Share by Type in 2019
1.2.3 Chemotherapy
1.2.4 Surgery
1.2.5 Radiation Therapy
1.2.6 Others
1.3 Global Non-Hematological Cancer Treatment Market by Application
1.3.1 Overview: Global Non-Hematological Cancer Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Oncology Treatment Centre
1.3.4 Ambulatory Surgery Centers
1.3.5 Others
1.4 Global Non-Hematological Cancer Treatment Market by Regions
1.4.1 Global Non-Hematological Cancer Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Non-Hematological Cancer Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Non-Hematological Cancer Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Non-Hematological Cancer Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Non-Hematological Cancer Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Non-Hematological Cancer Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Non-Hematological Cancer Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Non-Hematological Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Johnson & Johnson SWOT Analysis
2.2.4 Johnson & Johnson Product and Services
2.2.5 Johnson & Johnson Non-Hematological Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Non-Hematological Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Astellas Pharma
2.4.1 Astellas Pharma Details
2.4.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Astellas Pharma SWOT Analysis
2.4.4 Astellas Pharma Product and Services
2.4.5 Astellas Pharma Non-Hematological Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bristol-Myers Squibb SWOT Analysis
2.5.4 Bristol-Myers Squibb Product and Services
2.5.5 Bristol-Myers Squibb Non-Hematological Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Amgen SWOT Analysis
2.6.4 Amgen Product and Services
2.6.5 Amgen Non-Hematological Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Roche SWOT Analysis
2.7.4 Roche Product and Services
2.7.5 Roche Non-Hematological Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Non-Hematological Cancer Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Non-Hematological Cancer Treatment Players Market Share
3.2.2 Top 10 Non-Hematological Cancer Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Non-Hematological Cancer Treatment Revenue and Market Share by Regions
4.2 North America Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
5 North America Non-Hematological Cancer Treatment Revenue by Countries
5.1 North America Non-Hematological Cancer Treatment Revenue by Countries (2015-2020)
5.2 USA Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
6 Europe Non-Hematological Cancer Treatment Revenue by Countries
6.1 Europe Non-Hematological Cancer Treatment Revenue by Countries (2015-2020)
6.2 Germany Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
6.4 France Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Non-Hematological Cancer Treatment Revenue by Countries
7.1 Asia-Pacific Non-Hematological Cancer Treatment Revenue by Countries (2015-2020)
7.2 China Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
7.5 India Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
8 South America Non-Hematological Cancer Treatment Revenue by Countries
8.1 South America Non-Hematological Cancer Treatment Revenue by Countries (2015-2020)
8.2 Brazil Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Non-Hematological Cancer Treatment by Countries
9.1 Middle East & Africa Non-Hematological Cancer Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Non-Hematological Cancer Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Non-Hematological Cancer Treatment Market Forecast by Type (2019-2024)
10.3 Chemotherapy Revenue Growth Rate (2015-2025)
10.4 Surgery Revenue Growth Rate (2015-2025)
10.5 Radiation Therapy Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Non-Hematological Cancer Treatment Market Segment by Application
11.1 Global Non-Hematological Cancer Treatment Revenue Market Share by Application (2015-2020)
11.2 Non-Hematological Cancer Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Oncology Treatment Centre Revenue Growth (2015-2020)
11.5 Ambulatory Surgery Centers Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Non-Hematological Cancer Treatment Market Size Forecast (2021-2025)
12.1 Global Non-Hematological Cancer Treatment Market Size Forecast (2021-2025)
12.2 Global Non-Hematological Cancer Treatment Market Forecast by Regions (2021-2025)
12.3 North America Non-Hematological Cancer Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Non-Hematological Cancer Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Non-Hematological Cancer Treatment Revenue Market Forecast (2021-2025)
12.6 South America Non-Hematological Cancer Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Non-Hematological Cancer Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Non-Hematological Cancer Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Non-Hematological Cancer Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Non-Hematological Cancer Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Non-Hematological Cancer Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Novartis Corporate Information, Location and Competitors
Table 6. Novartis Non-Hematological Cancer Treatment Major Business
Table 7. Novartis Non-Hematological Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Novartis SWOT Analysis
Table 9. Novartis Non-Hematological Cancer Treatment Product and Solutions
Table 10. Novartis Non-Hematological Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Johnson & Johnson Corporate Information, Location and Competitors
Table 12. Johnson & Johnson Non-Hematological Cancer Treatment Major Business
Table 13. Johnson & Johnson Non-Hematological Cancer Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Johnson & Johnson SWOT Analysis
Table 15. Johnson & Johnson Non-Hematological Cancer Treatment Product and Solutions
Table 16. Johnson & Johnson Non-Hematological Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Pfizer Corporate Information, Location and Competitors
Table 18. Pfizer Non-Hematological Cancer Treatment Major Business
Table 19. Pfizer Non-Hematological Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Pfizer SWOT Analysis
Table 21. Pfizer Non-Hematological Cancer Treatment Product and Solutions
Table 22. Pfizer Non-Hematological Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Astellas Pharma Corporate Information, Location and Competitors
Table 24. Astellas Pharma Non-Hematological Cancer Treatment Major Business
Table 25. Astellas Pharma Non-Hematological Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Astellas Pharma SWOT Analysis
Table 27. Astellas Pharma Non-Hematological Cancer Treatment Product and Solutions
Table 28. Astellas Pharma Non-Hematological Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 30. Bristol-Myers Squibb Non-Hematological Cancer Treatment Major Business
Table 31. Bristol-Myers Squibb Non-Hematological Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Bristol-Myers Squibb SWOT Analysis
Table 33. Bristol-Myers Squibb Non-Hematological Cancer Treatment Product and Solutions
Table 34. Bristol-Myers Squibb Non-Hematological Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Amgen Corporate Information, Location and Competitors
Table 36. Amgen Non-Hematological Cancer Treatment Major Business
Table 37. Amgen Non-Hematological Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Amgen SWOT Analysis
Table 39. Amgen Non-Hematological Cancer Treatment Product and Solutions
Table 40. Amgen Non-Hematological Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Roche Corporate Information, Location and Competitors
Table 42. Roche Non-Hematological Cancer Treatment Major Business
Table 43. Roche Non-Hematological Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Roche SWOT Analysis
Table 45. Roche Non-Hematological Cancer Treatment Product and Solutions
Table 46. Roche Non-Hematological Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Non-Hematological Cancer Treatment Revenue (Million USD) by Players (2015-2020)
Table 48. Global Non-Hematological Cancer Treatment Revenue Share by Players (2015-2020)
Table 49. Global Non-Hematological Cancer Treatment Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Non-Hematological Cancer Treatment Revenue Market Share by Regions (2015-2020)
Table 51. North America Non-Hematological Cancer Treatment Revenue by Countries (2015-2020)
Table 52. North America Non-Hematological Cancer Treatment Revenue Market Share by Countries (2015-2020)
Table 53. Europe Non-Hematological Cancer Treatment Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Non-Hematological Cancer Treatment Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Non-Hematological Cancer Treatment Revenue by Countries (2015-2020)
Table 56. South America Non-Hematological Cancer Treatment Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Non-Hematological Cancer Treatment Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Non-Hematological Cancer Treatment Revenue Market Share by Countries (2015-2020)
Table 59. Global Non-Hematological Cancer Treatment Revenue (Million USD) by Type (2015-2020)
Table 60. Global Non-Hematological Cancer Treatment Revenue Share by Type (2015-2020)
Table 61. Global Non-Hematological Cancer Treatment Revenue Forecast by Type (2021-2025)
Table 62. Global Non-Hematological Cancer Treatment Revenue by Application (2015-2020)
Table 63. Global Non-Hematological Cancer Treatment Revenue Share by Application (2015-2020)
Table 64. Global Non-Hematological Cancer Treatment Revenue Forecast by Application (2021-2025)
Table 65. Global Non-Hematological Cancer Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Non-Hematological Cancer Treatment Picture
Figure 2. Global Non-Hematological Cancer Treatment Revenue Market Share by Type in 2019
Figure 3. Chemotherapy Picture
Figure 4. Surgery Picture
Figure 5. Radiation Therapy Picture
Figure 6. Others Picture
Figure 7. Non-Hematological Cancer Treatment Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Oncology Treatment Centre Picture
Figure 10. Ambulatory Surgery Centers Picture
Figure 11. Others Picture
Figure 12. Global Non-Hematological Cancer Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Non-Hematological Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Non-Hematological Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Non-Hematological Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Non-Hematological Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Non-Hematological Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Non-Hematological Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Non-Hematological Cancer Treatment Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Non-Hematological Cancer Treatment Revenue Market Share in 2019
Figure 21. Global Top 10 Players Non-Hematological Cancer Treatment Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Non-Hematological Cancer Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Non-Hematological Cancer Treatment Revenue Market Share by Regions (2015-2020)
Figure 25. Global Non-Hematological Cancer Treatment Revenue Market Share by Regions in 2018
Figure 26. North America Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Europe Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 29. South America Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 31. North America Non-Hematological Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 32. North America Non-Hematological Cancer Treatment Revenue Market Share by Countries in 2019
Figure 33. USA Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Canada Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 36. Europe Non-Hematological Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Non-Hematological Cancer Treatment Revenue Market Share by Countries in 2019
Figure 38. Germany Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 39. UK Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 40. France Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Russia Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Italy Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Non-Hematological Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Non-Hematological Cancer Treatment Revenue Market Share by Countries in 2019
Figure 45. China Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Japan Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Korea Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 48. India Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 50. South America Non-Hematological Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 51. South America Non-Hematological Cancer Treatment Revenue Market Share by Countries in 2019
Figure 52. Brazil Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Non-Hematological Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Non-Hematological Cancer Treatment Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 57. UAE Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Non-Hematological Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 60. Global Non-Hematological Cancer Treatment Revenue Share by Type (2015-2020)
Figure 61. Global Non-Hematological Cancer Treatment Revenue Share by Type in 2019
Figure 62. Global Non-Hematological Cancer Treatment Market Share Forecast by Type (2021-2025)
Figure 63. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 64. Global Surgery Revenue Growth Rate (2015-2020)
Figure 65. Global Radiation Therapy Revenue Growth Rate (2015-2020)
Figure 66. Global Others Revenue Growth Rate (2015-2020)
Figure 67. Global Non-Hematological Cancer Treatment Revenue Share by Application (2015-2020)
Figure 68. Global Non-Hematological Cancer Treatment Revenue Share by Application in 2019
Figure 69. Global Non-Hematological Cancer Treatment Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 71. Global Oncology Treatment Centre Revenue Growth Rate (2015-2020)
Figure 72. Global Ambulatory Surgery Centers Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Non-Hematological Cancer Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Non-Hematological Cancer Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Non-Hematological Cancer Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Non-Hematological Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 78. Europe Non-Hematological Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Non-Hematological Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 80. South America Non-Hematological Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Non-Hematological Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
非血液がんの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Non-Hematological Cancers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Non-Hematological C…- 基底細胞皮膚癌治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Basal Cell Skin Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…
- 耳がん治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Ear Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 大腸がん治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Colorectal Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 前立腺がん治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Prostate Cancer Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prostate Canc…